Hemoteq AG

🔵 We're ready to go for the Compamed 2024 tradeshow 🔴 See you in Düsseldorf from November 11th - 14th, booth 8b H01! We are looking forward to meeting new customers as well as our existing partners. Please reach out to schedule a meeting or stop by our booth. Let's talk about how we can innovate together 💡 #Compamed #DrugCoatings #HydrophilicCoatings #InnovatingTogether

What a year for Drug-Coated Balloons! This last 12 months has been a period of significant progress for both the clinical adoption of Drug-Coated Balloons and the team at Freudenberg Medical’s Hemoteq AG. Curious about what’s been happening? Tune into a conversation extracted from DeviceTalks recent AbbottTalks podcast, where Júlia Lleixà Calvet Ph.D., Director of Business Development, at Freudenberg Medical & Hemoteq AG and Kayleen Brown, DeviceTalks recap on an exciting year. #DeviceTalks #InnovatingTogether #Medtech #DrugCoatedBalloons

🚨Drug Coated Balloons. Podcast Alert! 🚨    The convergence of medical devices and drugs is inspiring a new generation of innovative products that fundamentally improve patients’ outcomes. On the latest episode of DeviceTalks AbbottTalks podcast, Jennifer Jones-McMeans Ph.D, Divisional VP of Global Clinical Affairs, Abbott Vascular, and Brian G. DeRubertis, MD, FACS, Chief, Division of Vascular & Endovascular Surgery at Weill Cornell Medical Center discuss the growing treatment options for severe peripheral artery disease.    We’re excited to feature Júlia Lleixà Calvet Ph.D., Director of Business Development at Freudenberg Medical & Hemoteq AG, in this podcast episode. Júlia dives into the advancements in drug-coated balloons over the past year for both coronary and peripheral vascular applications. She also shares how Freudenberg is investing over $50M to scale operations and expand capacity to meet increasing customer demand for its drug/device solutions.     Join Tom Salemi and Kayleen Brown in this exciting conversation about MedTech innovation! Listen in now!   #DeviceTalks #Innovatingtogether #Medtech #DrugCoatedBalloons    https://lnkd.in/e7v5kgkB

🎉 Celebrating 25 years Hemoteq AG and 175 years Freudenberg Group! 🎉 We celebrated the double anniversary with our employees and their close families at our new site, where construction has begun in order to triple our footprint to 130.000 sq. ft. and add 150 new jobs by 2026. 🔴 Founded in 1999 as as spin-off from RWTH Aachen University, Hemoteq AG has been a leader in the drug coatings segment for 25 years. Hemoteq's long standing legacy in the Drug Eluting Stent and Drug Coated Balloon markets is shaped by innovations, customer orientation, pioneering spirit and sustainability. In 2015, Hemoteq became part of Freudenberg Medical through a majority acquisition. This strategic integration has driven our growth and innovation with our global customer base. 🔵 The Freudenberg Group has developed throughout its 175-year history into a global technology group with 52.000 employees in about 60 countries and sales of almost €12 billion. Ground-breaking innovations, international orientation, high quality, reliability, partnership with customers and sound finances have been the company cornerstones since 1849. The highlights of the celebration included: 🎤 Speeches by Dr. Michael Hoffmann, Dr. Mark Ostwald, Dr. Max Kley and Alfred Sonders (city mayor of Alsdorf) 🎞 History videos 🎵 Live music 🎨 Children games and activities 🍗🥗🥂 Tasty food and drinks 🎊 Much fun together Thank you to all employees for your commitment and dedication. To many more years of growth and innovation together! #Hemoteq #25YearsAnniversary #Freudenberg #175YearsAnniversary #InnovatingTogether

Today it has been a pleasure to welcome Dr. Frank Heislitz, CTO, and Thomas Herr, CFO, both Members of the Board of Management at Freudenberg Group. Together with the Management Team of Hemoteq, we have discussed our business and customers, as well as our goals and exciting company development for the coming years. We've also enjoyed the tour of our new facility and are happy to see your commitment to Hemoteq AG and Freudenberg Medical. Thank you for your visit! #InnovatingTogether #Hemoteq #FreudenbergMedical

Happy Holiday

The "leave nothing behind" principle offers significant benefits and reduces risks for patients,” explains Júlia Lleixà Calvet, Director of Business Development at Freudenberg Medical & Hemoteq AG. In a recent DeviceTalks podcast interview with Kayleen Brown, she discusses the rapid adoption of drug-coated balloons and provides insights into the Paclitaxel vs. Limus debate. Hear Júlia's perspective on the latest advancements in drug/device combination products in this insightful video segment. #Innovatingtogether #Medtech #DrugCoatedBalloons

🏗️$50 M+ investment 📈 3x existing footprint 👥50% increase in staff “Huge things are happening for Freudenberg Medical and Hemoteq AG right now” highlights Kayleen Brown in a recent DeviceTalks podcast interview. Júlia Lleixà Calvet Ph.D, Director of Business Development at Freudenberg Medical & Hemoteq AG dives into some recent announcements in this video excerpt. #InnovatingTogether #Medtech #DrugCoatedBalloons

The #1 email or call… 🚀25 years of innovation ✨100+ granted patents 💪300+ team members "When engineers need expert advice on applying a drug or functional coating to a Minimally Invasive device, we’re their #1 email or call," says Júlia Lleixà Calvet, Director of Business Development at Freudenberg Medical & Hemoteq AG. Discover why in this video snippet from a recent DeviceTalks podcast. #innovatingtogether #Medtech #drugcoatedballoons

Die #Hemoteq AG wächst weiterhin und beginnt, seine Kapazitäten in Alsdorf aufzubauen. In dieser Woche durften wir unseren 300. Mitarbeitenden begrüßen, der gleichzeitig der erste offizielle Mitarbeiter in Alsdorf ist. "Herzlich willkommen, Norman😊 Wir wünschen Dir einen guten Start und viel Erfolg in der Abteilung Product Development am unserem neuen Standort in Alsdorf" ------------------------------------------------------------------------- #Hemoteq AG continues to grow and is starting to build up its capacities in Alsdorf. This week we welcomed our 300th employee, who is also the first official employee in Alsdorf. "A warm welcome, Norman😊  We wish you a good start and every success in the Product Development department at our new site in Alsdorf"